The founder and former leader of Inhibikase Therapeutics is blazing a new biotech trail in an effort to get a beleaguered ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost ...

Azafaros has secured 132 million euros ($147 million) in series B funds that the Dutch biotech will use to push its rare ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Professor Emeritus Herb Boyer's discovery of recombinant DNA changed medicine, ushering in a new era in biological treatments ...

Bactana Corp., a biotech startup headquartered at UConn’s Technology Incubation Program in Farmington, announced Tuesday it ...

Puma Biotech (PBYI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose ...

Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.

or biotech startup Treeline Biosciences find new drug candidates by simulating molecules. Sign up here. Its software was originally written with central processor units, or CPUs, in mind during an ...

As a descendant of an Indigenous Amazonian tribe, Maria Astolfi was concerned about research she conducted as a graduate ...